NextCure reported earnings of -$ 1.29 per NXTC share on Nov 10, 2026, beating analysts' expectations by
| Report Date | Nov 10, 2026 |
|---|---|
| Forecasted EPS | -$ 0.90 |
| Earnings Per Share (Surprise) | -$ 1.29 (-$ 0.39) |
| Last Year's EPS | -$ 5.00 |
| EPS YoY Change |
Out of the last 36 earnings reporting periods, NextCure beat analysts’ expectations 6 times and fell short of expectations 26 time(s). NextCure reported earnings per share of -$ 1.29 in the last report falling to reach an estimated EPS of -$ 0.90 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 10, 2026 | -$ 0.90 | -$ 1.29 | -$ 3.22 | |
| Aug 6, 2026 | -$ 1.95 | -$ 2.80 | -$ 11.29 | |
| May 7, 2026 | -$ 1.81 | -$ 1.87 | -$ 4.68 | |
| Mar 5, 2026 | -$ 2.26 | -$ 0.81 | -$ 4.92 | |
| Nov 5, 2025 | -$ 4.06 | -$ 3.22 | -$ 4.92 | |
| Aug 7, 2025 | -$ 4.62 | -$ 11.29 | -$ 6.60 | |
| May 1, 2025 | -$ 4.80 | -$ 4.68 | -$ 7.32 | |
| Mar 6, 2025 | -$ 0.35 | -$ 4.92 | -$ 7.32 | |
| Nov 7, 2024 | -$ 0.38 | -$ 4.92 | -$ 6.24 | |
| Aug 1, 2024 | -$ 0.38 | -$ 6.60 | -$ 6.12 | |
| May 3, 2024 | -$ 0.46 | -$ 7.32 | -$ 7.68 | |
| May 2, 2024 | -$ 5.40 | -$ 7.32 | -$ 6.96 | |
| Mar 21, 2024 | -$ 0.54 | -$ 6.24 | -$ 7.44 | |
| Nov 2, 2023 | -$ 0.66 | -$ 6.12 | -$ 8.16 | |
| Aug 3, 2023 | -$ 0.60 | -$ 7.68 | -$ 7.80 | |
| May 4, 2023 | -$ 0.62 | -$ 6.96 | -$ 8.88 | |
| Mar 2, 2023 | -$ 0.65 | -$ 7.44 | -$ 7.32 | |
| Nov 3, 2022 | -$ 0.63 | -$ 8.16 | -$ 7.80 | |
| Aug 4, 2022 | -$ 0.72 | -$ 7.80 | -$ 7.80 | |
| May 5, 2022 | -$ 0.67 | -$ 8.88 | -$ 7.20 |
NextCure’s stock was trading at $ 6.27 on Nov 9, 2026 a day before the last earnings report was released.Following the release of the earnings report, NXTC’s price decreased to $ 5.98 on Nov 11, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 10, 2026 | -$ 1.29 | $ 6.27 | $ 5.98 | |
| Aug 6, 2026 | -$ 2.80 | $ 5.25 | $ 5.84 | |
| May 7, 2026 | -$ 1.87 | $ 10.72 | $ 9.76 | |
| Mar 5, 2026 | -$ 0.81 | $ 12.60 | $ 12.39 | |
| Nov 5, 2025 | -$ 3.22 | $ 9.64 | $ 9.82 | |
| Aug 7, 2025 | -$ 11.29 | $ 5.16 | $ 4.87 | |
| May 1, 2025 | -$ 4.68 | $ 5.58 | $ 5.31 | |
| Mar 6, 2025 | -$ 4.92 | $ 8.88 | $ 9.00 | |
| Nov 7, 2024 | -$ 4.92 | $ 15.72 | $ 15.48 | |
| Aug 1, 2024 | -$ 6.60 | $ 19.44 | $ 19.20 | |
| May 3, 2024 | -$ 7.32 | $ 17.88 | $ 19.80 | |
| May 2, 2024 | -$ 7.32 | $ 16.44 | $ 18.36 | |
| Mar 21, 2024 | -$ 6.24 | $ 16.92 | $ 22.80 | |
| Nov 2, 2023 | -$ 6.12 | $ 12.84 | $ 14.16 | |
| Aug 3, 2023 | -$ 7.68 | $ 21.00 | $ 20.40 | |
| May 4, 2023 | -$ 6.96 | $ 18.24 | $ 19.08 | |
| Mar 2, 2023 | -$ 7.44 | $ 18.84 | $ 18.00 | |
| Nov 3, 2022 | -$ 8.16 | $ 29.64 | $ 23.76 | |
| Aug 4, 2022 | -$ 7.80 | $ 51.48 | $ 56.52 | |
| May 5, 2022 | -$ 8.88 | $ 47.76 | $ 45.60 |
NextCure released its most recent earnings reports in November 2026, August 2026, May 2026, March 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
NextCure missed analysts’ expectations during the last earnings period by
